Andreas Halvorsen's TEVA Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 2.5M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $51.15 M, representing 0.13% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Andreas Halvorsen has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2015, adding 16.2M shares. Largest reduction occurred in Q3 2024, reducing 12.1M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Andreas Halvorsen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +228,600 | New Buy | 228,600 | $62.30 |
| Q2 2015 | -228,600 | Sold Out | 228,600 | $0.00 |
| Q3 2015 | +8.87 M | New Buy | 8.87 M | $56.46 |
| Q4 2015 | +16.17 M | Add 182.26% | 25.04 M | $65.64 |
| Q1 2016 | +7.93 M | Add 31.66% | 32.97 M | $53.51 |
| Q2 2016 | -5.23 M | Reduce 15.88% | 27.74 M | $50.23 |
| Q3 2016 | -8.05 M | Reduce 29.03% | 19.68 M | $46.01 |
| Q4 2016 | -19.68 M | Sold Out | 19.68 M | $0.00 |
| Q3 2024 | +7.57 M | New Buy | 7.57 M | $18.02 |
| Q4 2024 | -1.06 M | Reduce 14.06% | 6.5 M | $22.04 |
| Q1 2025 | +3.62 M | Add 55.69% | 10.13 M | $15.37 |
| Q2 2025 | +1.56 M | Add 15.37% | 11.68 M | $16.76 |
| Q3 2025 | -9.15 M | Reduce 78.32% | 2.53 M | $20.20 |
Andreas Halvorsen's Teva Pharmaceutical Industries Limited Investment FAQs
Andreas Halvorsen first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q1 2015, acquiring 228,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Teva Pharmaceutical Industries Limited (TEVA) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q4 2015, adding 25,043,775 shares worth $1.64 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 2,532,119 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $51.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.13% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 32,971,622 shares, as reported at the end of Q1 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.